International Biotechnology Trust PLC Harmony Biosciences Holdings, Inc. Transaction History
International Biotechnology Trust PLC
- $295 Million
- Q3 2023
A detailed history of International Biotechnology Trust PLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 314,500 shares of HRMY stock, worth $10.3 Million. This represents 3.5% of its overall portfolio holdings.
Number of Shares
314,500
Previous 570,500
44.87%
Holding current value
$10.3 Million
Previous $20.1 Million
48.66%
% of portfolio
3.5%
Previous 6.26%
Shares
7 transactions
Others Institutions Holding HRMY
# of Institutions
242Shares Held
45.2MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$368 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$191 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$114 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$85.5 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.93MShares$63.2 Million0.18% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.94B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...